Schedule 13G ownership disclosure

Bright Minds Biosciences Inc

Common Shares, without par value · CUSIP: 10919W405

Event date: 2025-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Perceptive Advisors LLC

    Shares: 449,290 · Class: 4.6%

  • Joseph Edelman

    Shares: 449,290 · Class: 4.6%

  • Perceptive Life Sciences Master Fund, Ltd.

    Shares: 449,290 · Class: 4.6%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-26-054519
Form type
SCHEDULE 13G/A
Filer
BRIGHT MINDS BIOSCIENCES INC.
CIK
CIK 1827401
Filed
Feb 17, 2026
Reporting period
Dec 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub